VOLITIONRX LTD — Director's Dealing 2020

Aug 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2020-08-17

Reporting Person: Gaetan Michel (Manager-Belgian Volition SPRL)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-17	Common Stock	M	2500	$2.5	Acquired	2500	Direct
2020-08-17	Common Stock	F	1786	$3.5	Disposed	714	Direct
2020-08-17	Common Stock	M	2500	$3	Acquired	3214	Direct
2020-08-17	Common Stock	F	2143	$3.5	Disposed	1071	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-17	Stock Option (Right to Buy)	$2.5	M	2500	Disposed	2020-08-18	Common Stock (2500)	Direct
2020-08-17	Stock Option (Right to Buy)	$3	M	2500	Disposed	2020-08-18	Common Stock (2500)	Direct

Footnotes

F1: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise by the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction.